CRC
TMO icon

Curi RMB Capital’s Thermo Fisher Scientific TMO Stock Holding History

Curi RMB Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Hold
11,000
– – 0.09% 229
2026
Q1 		$5.41M Buy
+11,000
New +$5.97M 0.1% 207

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Curi RMB Capital's TMO Position: Q2 2026 in Review

Curi RMB Capital increased its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, buying an estimated $3.21M and bringing the position to 53,292 shares worth $26.7M. The position accounts for 0.41% of the portfolio, ranked #65.

Curi RMB Capital first reported a position in TMO in Q2 2017 and has held it in 37 quarters since. 2,629 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Curi RMB Capital held 53,292 shares of Thermo Fisher Scientific worth $26.7M as of Q2 2026.
  • Curi RMB Capital bought 6,695 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.21M.
  • Thermo Fisher Scientific made up 0.41% of Curi RMB Capital's portfolio in Q2 2026, its #65 holding.
  • Curi RMB Capital first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 37 quarters since.
  • 2,629 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.